NO308471B1 - FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef - Google Patents
FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbefInfo
- Publication number
- NO308471B1 NO308471B1 NO973835A NO973835A NO308471B1 NO 308471 B1 NO308471 B1 NO 308471B1 NO 973835 A NO973835 A NO 973835A NO 973835 A NO973835 A NO 973835A NO 308471 B1 NO308471 B1 NO 308471B1
- Authority
- NO
- Norway
- Prior art keywords
- loracarbef
- processes
- preparation
- monohydrate
- anhydrate form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/396,948 US5580977A (en) | 1995-03-01 | 1995-03-01 | Process for preparing loracarbef monohydrate |
| PCT/US1996/002586 WO1996026942A1 (en) | 1995-03-01 | 1996-02-28 | A process for preparing loracarbef monohydrate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO973835L NO973835L (no) | 1997-08-20 |
| NO973835D0 NO973835D0 (no) | 1997-08-20 |
| NO308471B1 true NO308471B1 (no) | 2000-09-18 |
Family
ID=23569249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973835A NO308471B1 (no) | 1995-03-01 | 1997-08-20 | FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5580977A (no) |
| EP (1) | EP0729959B1 (no) |
| JP (1) | JPH11501032A (no) |
| KR (1) | KR19980702666A (no) |
| CN (1) | CN1061349C (no) |
| AR (1) | AR002709A1 (no) |
| AT (1) | ATE184006T1 (no) |
| AU (1) | AU694639B2 (no) |
| BR (1) | BR9607308A (no) |
| CA (1) | CA2213812A1 (no) |
| CO (1) | CO4700429A1 (no) |
| CZ (1) | CZ272897A3 (no) |
| DE (1) | DE69603995T2 (no) |
| DK (1) | DK0729959T3 (no) |
| ES (1) | ES2135165T3 (no) |
| GR (1) | GR3031947T3 (no) |
| HU (1) | HUP9702151A3 (no) |
| IL (1) | IL117228A (no) |
| NO (1) | NO308471B1 (no) |
| NZ (1) | NZ304534A (no) |
| PE (1) | PE28097A1 (no) |
| PL (1) | PL322111A1 (no) |
| RU (1) | RU2160261C2 (no) |
| SI (1) | SI0729959T1 (no) |
| TR (1) | TR199700877T1 (no) |
| TW (1) | TW330205B (no) |
| WO (1) | WO1996026942A1 (no) |
| ZA (1) | ZA961341B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2222614T3 (es) | 1997-11-12 | 2005-02-01 | Mitsubishi Chemical Corporation | Derivados de purina y medicina que los contiene como ingrediente activo. |
| DE60006663T2 (de) | 1999-05-11 | 2004-10-07 | Mitsubishi Chem Corp | Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung |
| US6562974B2 (en) | 2000-02-01 | 2003-05-13 | The Procter & Gamble Company | Process for making geminal bisphosphonates |
| US6410520B2 (en) | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| WO2004046142A1 (en) * | 2002-11-21 | 2004-06-03 | Ranbaxy Laboratories Limited | Monohydrate solvates of loracarbef |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3502663A (en) * | 1969-04-21 | 1970-03-24 | Lilly Co Eli | Crystalline cephalosporin,method for its manufacture |
| US3531481A (en) * | 1969-04-21 | 1970-09-29 | Lilly Co Eli | Method for manufacture of crystalline cephalosporin |
| US4775751A (en) * | 1985-06-03 | 1988-10-04 | Eli Lilly & Company | Process for cephalexin hydrochloride alcoholates |
| DD273634A5 (de) * | 1987-10-06 | 1989-11-22 | ����@�����@�����@����k�� | Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins |
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
| US4977257A (en) * | 1988-11-14 | 1990-12-11 | Eli Lilly And Company | DMF solvates of a β-lactam antibiotic |
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
| US5374719A (en) * | 1993-06-04 | 1994-12-20 | Eli Lilly And Company | Process for converting loracarbef dihydrate to loracarbef monohydrate |
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
-
1995
- 1995-03-01 US US08/396,948 patent/US5580977A/en not_active Expired - Lifetime
-
1996
- 1996-02-20 ZA ZA9601341A patent/ZA961341B/xx unknown
- 1996-02-21 AR ARP960101460A patent/AR002709A1/es not_active Application Discontinuation
- 1996-02-22 IL IL11722896A patent/IL117228A/xx active IP Right Grant
- 1996-02-24 TW TW085102100A patent/TW330205B/zh active
- 1996-02-26 PE PE1996000129A patent/PE28097A1/es not_active Application Discontinuation
- 1996-02-26 CO CO96008863A patent/CO4700429A1/es unknown
- 1996-02-27 AT AT96301303T patent/ATE184006T1/de not_active IP Right Cessation
- 1996-02-27 ES ES96301303T patent/ES2135165T3/es not_active Expired - Lifetime
- 1996-02-27 DK DK96301303T patent/DK0729959T3/da active
- 1996-02-27 SI SI9630108T patent/SI0729959T1/xx not_active IP Right Cessation
- 1996-02-27 DE DE69603995T patent/DE69603995T2/de not_active Expired - Fee Related
- 1996-02-27 EP EP96301303A patent/EP0729959B1/en not_active Expired - Lifetime
- 1996-02-28 CN CN96193438A patent/CN1061349C/zh not_active Expired - Fee Related
- 1996-02-28 TR TR97/00877T patent/TR199700877T1/xx unknown
- 1996-02-28 HU HU9702151A patent/HUP9702151A3/hu unknown
- 1996-02-28 CA CA002213812A patent/CA2213812A1/en not_active Abandoned
- 1996-02-28 AU AU51742/96A patent/AU694639B2/en not_active Ceased
- 1996-02-28 JP JP8526365A patent/JPH11501032A/ja not_active Ceased
- 1996-02-28 RU RU97116165/04A patent/RU2160261C2/ru active
- 1996-02-28 BR BR9607308A patent/BR9607308A/pt not_active Application Discontinuation
- 1996-02-28 WO PCT/US1996/002586 patent/WO1996026942A1/en not_active Application Discontinuation
- 1996-02-28 PL PL96322111A patent/PL322111A1/xx unknown
- 1996-02-28 KR KR1019970706072A patent/KR19980702666A/ko active IP Right Grant
- 1996-02-28 NZ NZ304534A patent/NZ304534A/en unknown
- 1996-02-28 CZ CZ972728A patent/CZ272897A3/cs unknown
-
1997
- 1997-08-20 NO NO973835A patent/NO308471B1/no not_active IP Right Cessation
-
1999
- 1999-11-25 GR GR990403040T patent/GR3031947T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO951630L (no) | Fremgangsmåte for administrering av azithromycin | |
| NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
| FI940769A (fi) | Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi | |
| NO307967B1 (no) | FremgangsmÕte og mellomprodukter for fremstilling av benzopyranforbindelser | |
| NO981433D0 (no) | Fremgangsmåte for fremstilling av piperidinderivater | |
| NO982237L (no) | FremgangsmÕte for fremstilling av fenylimidazolidinderivater | |
| NO954322D0 (no) | Krystallins monohydrat av spirostanyl-glykosid | |
| IL117574A0 (en) | Processes for the preparation of cyclobutanone derivatives | |
| NO994505L (no) | Forbedret fremgangsmåte for fremstilling av tiazolidindioner og nye tiazolidindioner | |
| NO20001387L (no) | FremgangsmÕte for syntese av kinolinderivater | |
| NO943652D0 (no) | Fremgangsmåte for fremstilling av 3-aminopyridiner fra 3-nitropyridiner | |
| NO308471B1 (no) | FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef | |
| NO932860D0 (no) | Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat | |
| NO992058D0 (no) | FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler | |
| NO963187D0 (no) | Fremgangsmåte for syntese av gamma-pyroner | |
| NO940171D0 (no) | Fremgangsmaate for kontinuerlig fremstilling av dimetoksyetanal | |
| NO955082L (no) | Fremgangsmåte for fremstilling av glutardialdehyd | |
| NO20012099D0 (no) | Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser | |
| NO305363B1 (no) | FremgangsmÕte for fremstilling av substituerte indolonderivater og forbindelsene derav | |
| NO942531D0 (no) | Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener | |
| NO932616D0 (no) | Fremgangsmaate for fremstilling av fysostigminkarbonatderivater fra fysostigmin | |
| FI951723A0 (fi) | Menetelmä puhtaan podofyllotoksiinin valmistamiseksi | |
| EE9900264A (et) | Tetrahüdropüridiinderivaadi kristallisatsioonimeetod ja moodustuvad kristalsed vormid | |
| NO962809D0 (no) | Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater | |
| NO972129D0 (no) | Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN AUGUST 2002 |